Purchases and Sales Made in Q3 2021 in Pasithea Therapeutics Corp. (KTTA)

KTTA Quotes by TradingView

This table provides information about the institutional ownership of Pasithea Therapeutics Corp. (KTTA) during Q3 2021. The information is specifically focused on institutions that hold shares of Pasithea Therapeutics Corp..

Report Date Institution (Fund) Operation Option Shares change Value Range Shares Held Trade History
Nov 12, 2021 Q3 2021
Kepos Capital LP

New York, NY
BUY
 -
400K
New
$21.9M - $28.5M
400K $1.23M
Nov 15, 2021 Q3 2021
Two Sigma Securities, LLC

New York, NY
BUY
 -
10.4K
New
$572K - $743K
10.4K $32.1K
Nov 15, 2021 Q3 2021
Ubs Group Ag

BUY
 -
3.29K
New
$180K - $234K
3.29K $10.1K
Nov 15, 2021 Q3 2021
Tower Research Capital LLC (Trc)

New York, NY
BUY
 -
1.83K
New
$101K - $131K
1.83K $5.63K
Nov 09, 2021 Q3 2021
Concourse Financial Group Securities, Inc.

Birmingham, AL
BUY
 -
0
New
$0 - $0
0 $0

Track Institutional and Insider Activities on KTTA

Follow Pasithea Therapeutics Corp. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells KTTA shares.

Notify only if

Insider Trading

Get notified when an Pasithea Therapeutics Corp. insider buys or sells KTTA shares.

Notify only if

News

Receive news related to Pasithea Therapeutics Corp.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on KTTA